Cargando…
Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18
Heterologous immunization is garnering attention as a promising strategy to improve vaccine efficacy. Vaccines based on recombinant baculovirus (rBV) and virus-like particle (VLP) are safe for use, but heterologous immunization studies incorporating these two vaccine platforms remain unreported to d...
Autores principales: | Yoon, Keon-Woong, Chu, Ki-Back, Kang, Hae-Ji, Kim, Min-Ju, Eom, Gi-Deok, Mao, Jie, Lee, Su-Hwa, Ahmed, Md Atique, Quan, Fu-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609909/ https://www.ncbi.nlm.nih.gov/pubmed/36298453 http://dx.doi.org/10.3390/vaccines10101588 |
Ejemplares similares
-
Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
por: Yoon, Keon-Woong, et al.
Publicado: (2021) -
Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection
por: Kang, Hae-Ji, et al.
Publicado: (2018) -
Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of Toxoplasma gondii Infection
por: Kim, Min-Ju, et al.
Publicado: (2022) -
Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein
por: Eom, Gi-Deok, et al.
Publicado: (2023) -
Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection
por: Yoon, Keon-Woong, et al.
Publicado: (2022)